PE20120362A1 - Derivados de tiadiazoles y oxadiazoles, su preparacion y su aplicacion en terapia - Google Patents
Derivados de tiadiazoles y oxadiazoles, su preparacion y su aplicacion en terapiaInfo
- Publication number
- PE20120362A1 PE20120362A1 PE2011001392A PE2011001392A PE20120362A1 PE 20120362 A1 PE20120362 A1 PE 20120362A1 PE 2011001392 A PE2011001392 A PE 2011001392A PE 2011001392 A PE2011001392 A PE 2011001392A PE 20120362 A1 PE20120362 A1 PE 20120362A1
- Authority
- PE
- Peru
- Prior art keywords
- cycloalkyl
- absent
- thadiazol
- ilcarbamoyl
- tiadiazoles
- Prior art date
Links
- FRYPWUYDPUBMRU-UHFFFAOYSA-N 2-[(4-chlorophenoxy)methyl]-5-(2,4-dichloro-5-fluorophenyl)-1,3,4-oxadiazole Chemical compound C1=C(Cl)C(F)=CC(C=2OC(COC=3C=CC(Cl)=CC=3)=NN=2)=C1Cl FRYPWUYDPUBMRU-UHFFFAOYSA-N 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 150000001721 carbon Chemical group 0.000 abstract 2
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical class [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 abstract 2
- 208000032928 Dyslipidaemia Diseases 0.000 abstract 1
- 206010019708 Hepatic steatosis Diseases 0.000 abstract 1
- 208000017170 Lipid metabolism disease Diseases 0.000 abstract 1
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical group [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003626 triacylglycerols Chemical class 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Virology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE TIADIAZOLES Y OXADIAZOLES DE FORMULA (I) DONDE U ES N U O; D ES O, NH O UN ENLACE; n ES DE 0 A 3; p ES DE 0 A 2; W ES C O N; X ES S U O; R1, R2, R3 Y R4 SON CADA UNO H, ALQUILO(C1-C6) O R1 Y R2 FORMAN JUNTO AL ATOMO DE CARBONO AL QUE ESTAN UNIDOS UN CICLOALQUILO(C3-C10) O R3 Y R4 FORMAN JUNTO AL ATOMO DE CARBONO AL QUE ESTAN UNIDOS UN CICLOALQUILO(C3-C10); Y ES H, ALQUILO(C1-C6), CICLOALQUIL(C3-C10)-OXILO; CICLOALQUILO(C3-C10), ENTRE OTROS; R ES H O HALOGENO; Z1 ESTA AUSENTE O ES S, -NH, -NHC(O), -S(O)-CH2, ENTRE OTROS; Z2 ESTA AUSENTE O ES METILENO; Z3 ESTA AUSENTE O ES O U METILENO; Z4 ESTA AUSENTE O ES H O C QUE FORMA CON Z3 UN CICLOALQUILO(C3-C10); R5 ES H, HETEROCICLOALQUILALQUILO(C1-C6), ALQUILO OPCIONALMENTE SUSTITUIDO CON HIDROXILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: ACIDO {4-[4-(5-BENCIL-[1,3,4]TIADIAZOL-2-ILCARBAMOIL)FENIL]CICLOHEXIL}ACETICO; ACIDO CIS-4-[4-(5-BENCIL-[1,3,4]TIADIAZOL-2-ILCARBAMOIL)-2-CLOROFENOXI]CICLOHEXANO-CARBOXILICO; ACIDO TRANS-{4-[4-(5-BENCILSULFANILMETIL-[1,3,4]TIADIAZOL-2-ILCARBAMOIL)FENIL]CICLOHEXIL}ACETICO; ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS INHIBEN LA BIOSINTESIS DE TRIGLICERIDOS SIENDO UTILES EN EL TRATAMIENTO DE OBESIDAD, DISLIPIDEMIA, ESTEATOSIS HEPATICA, DIABETES TIPO 2, SINDROME METABOLICO
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0900359A FR2941457A1 (fr) | 2009-01-28 | 2009-01-28 | Derives de thiadiazoles et d'oxadiazoles leur preparation et leur application en therapeutique |
| FR0904137A FR2949464B1 (fr) | 2009-09-01 | 2009-09-01 | Derives de thiadiazoles et d'oxadiazoles, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20120362A1 true PE20120362A1 (es) | 2012-05-04 |
Family
ID=42261833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2011001392A PE20120362A1 (es) | 2009-01-28 | 2010-01-27 | Derivados de tiadiazoles y oxadiazoles, su preparacion y su aplicacion en terapia |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US8546391B2 (es) |
| EP (1) | EP2391611B1 (es) |
| JP (1) | JP2012516312A (es) |
| KR (1) | KR20110112845A (es) |
| CN (1) | CN102365273A (es) |
| AR (1) | AR075177A1 (es) |
| AU (1) | AU2010209545A1 (es) |
| BR (1) | BRPI1007414A2 (es) |
| CA (1) | CA2750742A1 (es) |
| CL (1) | CL2011001839A1 (es) |
| CO (1) | CO6400221A2 (es) |
| CR (1) | CR20110403A (es) |
| DO (1) | DOP2011000245A (es) |
| EA (1) | EA201170983A1 (es) |
| EC (1) | ECSP11011224A (es) |
| IL (1) | IL214260A0 (es) |
| MA (1) | MA33069B1 (es) |
| MX (1) | MX2011007991A (es) |
| NI (1) | NI201100149A (es) |
| NZ (1) | NZ594244A (es) |
| PE (1) | PE20120362A1 (es) |
| TN (1) | TN2011000353A1 (es) |
| TW (1) | TW201031645A (es) |
| UY (1) | UY32405A (es) |
| WO (1) | WO2010086551A1 (es) |
| ZA (1) | ZA201105525B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2963005B1 (fr) | 2010-07-23 | 2012-08-17 | Sanofi Aventis | Derives d'oxadiazoles et de pyridazines, leur preparation et leur application en therapeutique |
| CN102557941B (zh) * | 2010-12-07 | 2015-04-22 | 成都睿智化学研究有限公司 | 一种螺环丙基甲酰衍生物的中间体化合物的制备方法 |
| EP2903985A1 (en) * | 2012-10-03 | 2015-08-12 | Advinus Therapeutics Limited | Spirocyclic compounds, compositions and medicinal applications thereof |
| WO2014060381A1 (de) * | 2012-10-18 | 2014-04-24 | Bayer Cropscience Ag | Heterocyclische verbindungen als schädlingsbekämpfungsmittel |
| AU2014352830B2 (en) * | 2013-11-21 | 2018-12-13 | Concordia University, Inc. | Substituted (4'-hydroxyphenyl)cycloalkane compounds and uses thereof as selective agonists of the estrogen receptor beta isoform |
| WO2015106272A1 (en) * | 2014-01-13 | 2015-07-16 | Harki Daniel A | Small molecule inhibitors of apobec3g and apobec3b |
| EP3034500A1 (en) | 2014-12-17 | 2016-06-22 | Genkyotex Sa | Amido thiazole derivatives as NADPH oxidase inhibitors |
| JP6483272B2 (ja) * | 2015-02-17 | 2019-03-13 | グアンジョウ インスティテュート オブ バイオメディスン アンド ヘルス，チャイニーズ アカデミー オブ サイエンスィズ | 白色脂肪組織の褐色化を誘導するための化合物および方法 |
| CN106278895B (zh) * | 2015-05-15 | 2021-07-09 | Dic株式会社 | 羧酸化合物、其制造方法、使用该化合物的液晶组合物 |
| WO2019193540A1 (en) * | 2018-04-06 | 2019-10-10 | Glaxosmithkline Intellectual Property Development Limited | Heteroaryl derivatives of formula (i) as atf4 inhibitors |
| WO2023060573A1 (en) * | 2021-10-15 | 2023-04-20 | Beijing Danatlas Pharmaceutical Co., Ltd. | Novel thiadiazolyl derivatives of dna polymerase theta inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6100077A (en) | 1998-10-01 | 2000-08-08 | The Trustees Of Columbia University In The City Of New York | Isolation of a gene encoding diacylglycerol acyltransferase |
| FR2840301B1 (fr) | 2002-05-29 | 2007-03-23 | Sanofi Synthelabo | Derives de phenyl-cyclohexyl-propanolamine, leur preparation et leur applicaton en therapeutique |
| WO2004004665A2 (en) * | 2002-07-09 | 2004-01-15 | Bristol-Myers Squibb Company | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| US20050143384A1 (en) * | 2003-10-30 | 2005-06-30 | Eric Sartori | Amide thiadiazole inhibitors of plasminogen activator inhibitor-1 |
| CN1909902A (zh) * | 2003-12-22 | 2007-02-07 | 伊莱利利公司 | 用于治疗糖尿病的作为ppar调节剂的三唑、噁二唑和噻二唑衍生物 |
| GB0427328D0 (en) * | 2004-12-14 | 2005-01-19 | Astrazeneca Ab | Chemical compounds |
| GB0511851D0 (en) * | 2005-06-11 | 2005-07-20 | Astrazeneca Ab | Chemical compounds |
| WO2006134317A1 (en) | 2005-06-11 | 2006-12-21 | Astrazeneca Ab | Oxadiazole derivatives as dgat inhibitors |
| EP2010479A1 (en) * | 2006-04-07 | 2009-01-07 | High Point Pharmaceuticals, LLC | 11 beta-hydroxysteroid dehydrogenase type 1 active compounds |
-
2010
- 2010-01-27 AU AU2010209545A patent/AU2010209545A1/en not_active Abandoned
- 2010-01-27 CA CA2750742A patent/CA2750742A1/fr not_active Abandoned
- 2010-01-27 CN CN2010800142290A patent/CN102365273A/zh active Pending
- 2010-01-27 PE PE2011001392A patent/PE20120362A1/es not_active Application Discontinuation
- 2010-01-27 TW TW099102288A patent/TW201031645A/zh unknown
- 2010-01-27 US US13/145,665 patent/US8546391B2/en not_active Expired - Fee Related
- 2010-01-27 JP JP2011546921A patent/JP2012516312A/ja not_active Withdrawn
- 2010-01-27 MA MA34128A patent/MA33069B1/fr unknown
- 2010-01-27 WO PCT/FR2010/050124 patent/WO2010086551A1/fr not_active Ceased
- 2010-01-27 KR KR1020117019841A patent/KR20110112845A/ko not_active Withdrawn
- 2010-01-27 NZ NZ594244A patent/NZ594244A/xx not_active IP Right Cessation
- 2010-01-27 EA EA201170983A patent/EA201170983A1/ru unknown
- 2010-01-27 MX MX2011007991A patent/MX2011007991A/es not_active Application Discontinuation
- 2010-01-27 BR BRPI1007414-7A patent/BRPI1007414A2/pt not_active IP Right Cessation
- 2010-01-27 AR ARP100100186A patent/AR075177A1/es not_active Application Discontinuation
- 2010-01-27 EP EP10707597.0A patent/EP2391611B1/fr active Active
- 2010-01-28 UY UY0001032405A patent/UY32405A/es not_active Application Discontinuation
-
2011
- 2011-07-15 TN TN2011000353A patent/TN2011000353A1/fr unknown
- 2011-07-24 IL IL214260A patent/IL214260A0/en unknown
- 2011-07-25 EC EC2011011224A patent/ECSP11011224A/es unknown
- 2011-07-26 CR CR20110403A patent/CR20110403A/es unknown
- 2011-07-27 NI NI201100149A patent/NI201100149A/es unknown
- 2011-07-27 ZA ZA2011/05525A patent/ZA201105525B/en unknown
- 2011-07-28 DO DO2011000245A patent/DOP2011000245A/es unknown
- 2011-07-28 CL CL2011001839A patent/CL2011001839A1/es unknown
- 2011-07-28 CO CO11094698A patent/CO6400221A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2391611A1 (fr) | 2011-12-07 |
| KR20110112845A (ko) | 2011-10-13 |
| BRPI1007414A2 (pt) | 2018-03-06 |
| EP2391611B1 (fr) | 2014-04-30 |
| TN2011000353A1 (fr) | 2013-03-27 |
| CN102365273A (zh) | 2012-02-29 |
| AR075177A1 (es) | 2011-03-16 |
| JP2012516312A (ja) | 2012-07-19 |
| ECSP11011224A (es) | 2011-08-31 |
| WO2010086551A1 (fr) | 2010-08-05 |
| CA2750742A1 (fr) | 2010-08-05 |
| UY32405A (es) | 2010-08-31 |
| CL2011001839A1 (es) | 2012-01-06 |
| NZ594244A (en) | 2013-07-26 |
| MX2011007991A (es) | 2011-11-18 |
| US8546391B2 (en) | 2013-10-01 |
| IL214260A0 (en) | 2011-09-27 |
| MA33069B1 (fr) | 2012-02-01 |
| CO6400221A2 (es) | 2012-03-15 |
| AU2010209545A1 (en) | 2011-08-18 |
| ZA201105525B (en) | 2012-12-27 |
| CR20110403A (es) | 2011-09-21 |
| DOP2011000245A (es) | 2011-09-15 |
| EA201170983A1 (ru) | 2012-03-30 |
| US20120040984A1 (en) | 2012-02-16 |
| NI201100149A (es) | 2011-11-01 |
| TW201031645A (en) | 2010-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20120362A1 (es) | Derivados de tiadiazoles y oxadiazoles, su preparacion y su aplicacion en terapia | |
| PE20120690A1 (es) | Derivados de 5-fluoropirimidinona | |
| MX2012015023A (es) | Derivado novedoso de nicotinamida o sal del mismo. | |
| PE20080970A1 (es) | Derivados de quinazolinona 5-sustituida y composiciones que los comprenden y metodos para utilizarlos | |
| IN2012DN00573A (es) | ||
| IN2012DN00709A (es) | ||
| PE20161475A1 (es) | Pirazolopiridinas y pirazolopirimidinas | |
| BRPI1007622B8 (pt) | Composto, composição, método não terapêutico para controlar um nematódeo parasítico e semente revestida | |
| PE20080671A1 (es) | DERIVADOS DE 2-ARIL-6-FENIL-IMIDAZO[1,2-a]PIRIDINAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA | |
| PE20090815A1 (es) | Compuesto de amida | |
| MX2010008637A (es) | Derivado de fenilpirrol novedoso. | |
| NO20080391L (no) | Pyrazolbaserte LXR modulatorer | |
| PE20091687A1 (es) | Derivados de piridina o pirazina como inhibidores de cinasa-pi-3 | |
| PE20090813A1 (es) | Inhibidores de la 11b-hidroxiesteroide-deshidrogenasa | |
| CL2012000999A1 (es) | Compuestos derivados de pirazoloespirocetona sustituida, inhibidores de acetil-coa carboxilasa; composicion farmaceutica que los comprende; uso para tratar o retrasar la progresion o el inicio de diabetes tipo 2, higado graso no alcoholico (hgna) o la resistencia hepatica a la insulina. | |
| PE20091694A1 (es) | DERIVADOS POLISUSTITUIDOS DE 6-HETEROARIL-IMIDAZO[1,2-a] PIRIDINAS COMO MODULADORES DE LOS RECEPTORES NOT Y SU PREPARACION | |
| WO2008126901A1 (ja) | 含窒素複素環化合物およびそれを含有する医薬組成物 | |
| PE20110420A1 (es) | Nuevos derivados de 2-amidotiadiazol | |
| CO6321269A2 (es) | Derivados de benzoxazinona que actuan como agonistas de receptores adrenergicos beta 2 para el tratamiento de transtornos respiratorios | |
| NO20083058L (no) | Cykloheksylsulfonamidderivater med H3 reseptor aktivitet | |
| BRPI1007456A2 (pt) | derivados de azaespiranil-alquilcarbamatos de compostos heterocíclicos com 5 membros, o respectivo preparo e a respectiva aplicação em terapêutica | |
| PE20141167A1 (es) | Piridopirazinas sustituidas como inhibidores novedosos de ptk | |
| DE602007001463D1 (de) | Pyrimidin-, chinazolin-, pteridin- und triazinderivate | |
| PE20090880A1 (es) | Compuestos heterociclicos como inhibidores de fosfatidilinositol 3-cinasa | |
| MX350862B (es) | Acidos de piperidinil naftilacetico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |